These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17936591)

  • 21. Lack of relationship of auditory gating defects to negative symptoms in schizophrenia.
    Adler LE; Waldo MC; Tatcher A; Cawthra E; Baker N; Freedman R
    Schizophr Res; 1990; 3(2):131-8. PubMed ID: 2278977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naïve schizophrenia.
    Xia L; Wang D; Wei G; Wang J; Zhou H; Xu H; Tian Y; Dai Q; Xiu M; Chen D; Wang L; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110246. PubMed ID: 33453321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sensory gating of patients with first-episode schizophrenia].
    Chen XS; Zhang MD; Wang HX; Lou CY; Wang JJ; Guo Q; Liu L; Gao CY; Liu P; Liu XW; Duan HJ; Guo FL; Liang JH; Chen C; Chen XW
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3457-9. PubMed ID: 16686059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in gating of the auditory evoked potential in normal subjects.
    Hetrick WP; Sandman CA; Bunney WE; Jin Y; Potkin SG; White MH
    Biol Psychiatry; 1996 Jan; 39(1):51-8. PubMed ID: 8719126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients.
    Brockhaus-Dumke A; Schultze-Lutter F; Mueller R; Tendolkar I; Bechdolf A; Pukrop R; Klosterkoetter J; Ruhrmann S
    Biol Psychiatry; 2008 Sep; 64(5):376-84. PubMed ID: 18395700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced P50 suppression is associated with the cognitive disorganisation dimension of schizotypy.
    Evans LH; Gray NS; Snowden RJ
    Schizophr Res; 2007 Dec; 97(1-3):152-62. PubMed ID: 17884353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia.
    Cullum CM; Harris JG; Waldo MC; Smernoff E; Madison A; Nagamoto HT; Griffith J; Adler LE; Freedman R
    Schizophr Res; 1993 Aug; 10(2):131-41. PubMed ID: 8398945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave.
    Nagamoto HT; Adler LE; Waldo MC; Griffith J; Freedman R
    Schizophr Res; 1991; 4(1):31-40. PubMed ID: 1848997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auditory evoked potential variability in healthy and schizophrenia subjects.
    Jansen BH; Hu L; Boutros NN
    Clin Neurophysiol; 2010 Aug; 121(8):1233-9. PubMed ID: 20363180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups.
    de Wilde OM; Bour LJ; Dingemans PM; Koelman JH; Linszen DH
    Schizophr Res; 2007 Dec; 97(1-3):137-51. PubMed ID: 17604606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
    Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects.
    Ghisolfi ES; Prokopiuk AS; Becker J; Ehlers JA; Belmonte-de-Abreu P; Souza DO; Lara DR
    Neuropsychopharmacology; 2002 Oct; 27(4):629-37. PubMed ID: 12377399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis.
    Olincy A; Martin L
    Am J Psychiatry; 2005 Jan; 162(1):43-9. PubMed ID: 15625200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auditory selective attention and event-related potentials in schizophrenia.
    Ward PB; Catts SV; Fox AM; Michie PT; McConaghy N
    Br J Psychiatry; 1991 Apr; 158():534-9. PubMed ID: 2054568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing the relative contribution of the first and second responses to sensory gating indices: a meta-analysis.
    Chang WP; Arfken CL; Sangal MP; Boutros NN
    Psychophysiology; 2011 Jul; 48(7):980-92. PubMed ID: 21214588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The P 300 potential in schizophrenia].
    Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P50 suppression deficits and psychopathology in Han Chinese patients with schizophrenia.
    Zhu XL; Tan SP; Wang ZR; Zhang JG; Li D; Fan FM; Zhao YL; Zou YZ; Tan YL; Yang F; Zhang XY
    Neurosci Lett; 2017 Jul; 653():346-350. PubMed ID: 28606770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent domains of inhibitory gating in schizophrenia and the effect of stimulus interval.
    Hong LE; Summerfelt A; Wonodi I; Adami H; Buchanan RW; Thaker GK
    Am J Psychiatry; 2007 Jan; 164(1):61-5. PubMed ID: 17202545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cognitive and P50 suppression deficits in chronic patients with schizophrenia.
    Xia L; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Zhang G; Du X; Jia Q; Zhu X; Wang L; Tang W; Zhang XY
    Clin Neurophysiol; 2020 Mar; 131(3):725-733. PubMed ID: 32000073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Event-related potentials in psychiatry--methodologic principles].
    Münte F; Künkel H
    Psychiatr Neurol Med Psychol (Leipz); 1990 Nov; 42(11):649-59. PubMed ID: 2093195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.